H2O America (HTO) Q3 2026 Earnings Call Transcript

H2O America reported Q3 adjusted diluted EPS of $1.04, down from $1.27 a year earlier, while revenue rose 4% to $250.2 million; management attributed the EPS decline largely to a roughly 20% increase in weighted average diluted shares and higher operating expenses. The company narrowed standalone 2026 adjusted EPS guidance to $3.10–$3.16, maintaining its $3.13 midpoint, and gave post-acquisition guidance of $2.91–$2.97 as it closed the Quadvest acquisition, which is expected to become accretive in 2028. Management kept its $2.7 billion five-year capital budget and expects 13% rate-base CAGR, while pursuing rate increases in Connecticut and Maine and citing interest rates and housing conditions as risks to growth.

Analysis

The key equity issue is conversion, not asset growth: HTO’s rate-base plan only creates shareholder value if regulators recognize investment promptly and financing costs do not absorb the allowed return. The 2026 company-funded CapEx reduction is not a demand signal, but developer-funded construction can defer the point at which HTO funds assets and earns on them. Meanwhile, the equity raised to fund acquisitions lowers per-share earnings before Quadvest’s stated 2028 accretion; 2027 is the clearest execution test, with a full year of acquisition-related dilution and stepped-up depreciation.

Near-term catalysts are the Connecticut decision expected in January 2027, Maine rates expected by May, and the Texas GRC filing in 1H27. The Texas SICC outcome is a warning that documentation and affordability scrutiny can lengthen regulatory lag even where infrastructure need is clear. California’s PFAS project adds a separate approval and recovery dependency into 2Q27. A further second-order risk is that higher borrowing costs can pressure both Houston-area housing connections and the valuation of long-duration regulated utilities; a strong development pipeline is not equivalent to committed near-term hookups.

Contrarian point: the 13% rate-base CAGR is not an EPS forecast. The market may be over-crediting the growth pipeline while underweighting dilution and rate-case timing. Conversely, if the upcoming rate awards support timely recovery, today’s share-count drag could mask improving underlying earnings. Without valuation and peer-relative pricing, there is not enough basis for an outright directional entry.

Key Decisions for Investors

• Treat HTO as a catalyst watch rather than buying the rate-base headline: reassess after the Connecticut decision and Maine order, focusing on awarded revenue versus requests and any indication of regulatory lag.
• For existing exposure, size against the 2027 dilution window; require evidence in 2027 guidance that Quadvest’s contribution and allowed rate base are overcoming acquisition depreciation and financing costs before underwriting 2028 accretion.
• Consider a relative long in HTO versus a regulated-water-utility peer basket only if HTO underperforms into the rate decisions while regulatory outcomes remain constructive; avoid an outright valuation call until current multiples, funding plans, and peer pricing are checked.
• Falsifiers: materially adverse Connecticut or Maine awards, a Texas filing delay or weak rate-base recognition, continued share issuance beyond the disclosed funding plan, or Houston connection growth rolling over. Positive confirmation would be timely rate recovery and 2027 per-share guidance that stabilizes despite the full-year acquisition effects.